180 related articles for article (PubMed ID: 32654457)
21. [A comparative study of induction chemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed young medium/high risk diffuse large B cell lymphoma patients].
Wang X; Xia B; Wang CY; Li MZ; Xu W; Yuan T; Tian C; Zhao HF; Yang HL; Zhao ZG; Wang XF; Wang YF; Yu Y; Zhang YZ
Zhonghua Xue Ye Xue Za Zhi; 2019 Feb; 40(2):117-124. PubMed ID: 30831626
[No Abstract] [Full Text] [Related]
22. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.
Castillo JJ; Furman M; Beltrán BE; Bibas M; Bower M; Chen W; Díez-Martín JL; Liu JJ; Miranda RN; Montoto S; Nanaji NM; Navarro JT; Seegmiller AC; Vose JM
Cancer; 2012 Nov; 118(21):5270-7. PubMed ID: 22510767
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological analysis of oral plasmablastic lymphoma: A systematic review.
Rodrigues-Fernandes CI; de Souza LL; Santos-Costa SFD; Silva AMB; Pontes HAR; Lopes MA; de Almeida OP; Brennan PA; Fonseca FP
J Oral Pathol Med; 2018 Nov; 47(10):915-922. PubMed ID: 29917262
[TBL] [Abstract][Full Text] [Related]
24. [Plasmablastic lymphoma].
Fernández-Álvarez R; Sancho JM; Ribera JM
Med Clin (Barc); 2016 Nov; 147(9):399-404. PubMed ID: 27576534
[TBL] [Abstract][Full Text] [Related]
25. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma.
Castillo JJ; Winer ES; Stachurski D; Perez K; Jabbour M; Milani C; Colvin G; Butera JN
Leuk Lymphoma; 2010 Nov; 51(11):2047-53. PubMed ID: 20919850
[TBL] [Abstract][Full Text] [Related]
26. HIV-negative plasmablastic lymphoma: not in the mouth.
Castillo JJ; Winer ES; Stachurski D; Perez K; Jabbour M; Milani C; Colvin GA; Butera JN
Clin Lymphoma Myeloma Leuk; 2011 Apr; 11(2):185-9. PubMed ID: 21575922
[TBL] [Abstract][Full Text] [Related]
27. [Plasmablastic lymphoma: a clinicopathologic analysis of 11 cases with review of literature].
Li F; Ding W; Zuo Z; Geng N; Yang H; Liu X; Wang J; Yao W; Liu W
Zhonghua Bing Li Xue Za Zhi; 2016 Jan; 45(1):37-42. PubMed ID: 26791552
[TBL] [Abstract][Full Text] [Related]
28. Survival analysis in treated plasmablastic lymphoma patients: a population-based study.
Florindez JA; Alderuccio JP; Reis IM; Lossos IS
Am J Hematol; 2020 Nov; 95(11):1344-1351. PubMed ID: 32777103
[TBL] [Abstract][Full Text] [Related]
29. Plasmablastic lymphoma in immunocompetent and in immunocompromised patients: Experience at a regional cancer centre in India.
Rudresha AH; Lakshmaiah KC; Agarwal A; Babu KG; Loknatha D; Jacob LA; Babu S; Lokesh KN; Rajeev LK
South Asian J Cancer; 2017; 6(2):69-71. PubMed ID: 28702410
[TBL] [Abstract][Full Text] [Related]
30. Plasmablastic lymphoma presenting as a large intracardiac mass and bilateral pleural effusions.
Qing X; Enbom E; Qing A; French S; Cai J
Exp Mol Pathol; 2016 Feb; 100(1):79-81. PubMed ID: 26607603
[TBL] [Abstract][Full Text] [Related]
31. HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases.
Li YJ; Li JW; Chen KL; Li J; Zhong MZ; Liu XL; Yi PY; Zhou H
Blood Res; 2020 Mar; 55(1):49-56. PubMed ID: 32269975
[TBL] [Abstract][Full Text] [Related]
32. High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma.
Miao L; Guo N; Feng Y; Rao H; Wang F; Huang Q; Huang Y
Histopathology; 2020 Jan; 76(2):201-211. PubMed ID: 31348551
[TBL] [Abstract][Full Text] [Related]
33. The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
Di Ciaccio PR; Polizzotto MN; Cwynarski K; Gerrie AS; Burton C; Bower M; Kuruvilla J; Montoto S; McKay P; Fox CP; Milliken S; Jiamsakul A; Osborne W; Collins GP; Manos K; Linton KM; Iyengar S; Kassam S; Limei MP; Kliman D; Wong Doo N; Watson AM; Fedele P; Yannakou CK; Hunt S; Ku M; Sehn LH; Smith A; Renshaw H; Maxwell A; Liu Q; Dhairyawan R; Ferguson G; Pickard K; Painter D; Thakrar N; Song KW; Hamad N
Blood; 2024 Jan; 143(2):152-165. PubMed ID: 37832030
[TBL] [Abstract][Full Text] [Related]
34. Plasmablastic Lymphoma: A Clinicopathological Study from a Tertiary Care Cancer Center in South India.
Mundada MC; Ahmed F; Khera R; Murthy S; Rajappa S; Santa A; Mallavarapu K
South Asian J Cancer; 2020 Jun; 9(2):105-108. PubMed ID: 33354553
[No Abstract] [Full Text] [Related]
35. Bortezomib in plasmablastic lymphoma: A glimpse of hope for a hard-to-treat disease.
Guerrero-Garcia TA; Mogollon RJ; Castillo JJ
Leuk Res; 2017 Nov; 62():12-16. PubMed ID: 28963907
[TBL] [Abstract][Full Text] [Related]
36. Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.
Foster WR; Bischin A; Dorer R; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):311-21. PubMed ID: 27234438
[TBL] [Abstract][Full Text] [Related]
37. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients.
Teruya-Feldstein J; Chiao E; Filippa DA; Lin O; Comenzo R; Coleman M; Portlock C; Noy A
Ann Oncol; 2004 Nov; 15(11):1673-9. PubMed ID: 15520070
[TBL] [Abstract][Full Text] [Related]
38. [Clinical analysis of autologous hematopoietic stem cell transplantation in the treatment of advanced/recurrent nasal type extranodal NK/T-cell lymphoma].
Yuan FF; Yin QS; Fu YW; Wang Q; Chen L; Mi RH; Li YF; Wei XD; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):569-572. PubMed ID: 30122016
[No Abstract] [Full Text] [Related]
39. Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China.
Shi D; Gao L; Wan XC; Li J; Tian T; Hu J; Zhang QL; Su YF; Zeng YP; Hu ZJ; Yu BH; Li XQ; Wei P; Li JW; Zhou XY
BMC Med; 2022 Dec; 20(1):483. PubMed ID: 36522654
[TBL] [Abstract][Full Text] [Related]
40. Plasmablastic Lymphoma. A State-of-the-Art Review: Part 1-Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Prognostic Factors, and Special Populations.
Bibas M
Mediterr J Hematol Infect Dis; 2024; 16(1):e2024007. PubMed ID: 38223486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
